INL researchers are part of the European consortium CROSSBRAIN – a groundbreaking project aimed at developing microbots to predict and prevent seizures in individuals suffering from conditions such as epilepsy or Alzheimer’s disease. Within the complexity of our brains, neurons communicate through various signalling mechanisms, including chemical, thermal, and electrical changes. Many neurological disorders affecting the brain originate from abnormal electrical activity, leading to conditions such as epileptic seizures. When these abnormalities in electrical activity occur, prompt identification and swift intervention are vital for effective treatment. However, current technologies for monitoring and modulating brain activity with precision are very limited. CROSSBRAIN brings together leading researchers from across Europe to develop a new solution for predicting and preventing seizures in neurological conditions. Coordinated by researchers from Tor Vergata University of Rome, the consortium aims to create micro-sized robots that can be implanted in our brains. By combining cutting-edge computing and nanomaterials, CROSSBRAIN will enable precise modulation of brain tissue using various stimulation methods, including electrical, mechanical, thermal, and optical principles. The microbots, powered wirelessly by a compact central unit, will then be implanted through blood vessels, with the capability to deliver genetic material. Once integrated into the network of neurons, these […]
Read more